Latest information on COVID-19

Researchers receive funding to study inflammatory bowel disease

Eight Stanford Medicine researchers have received grants from the Kenneth Rainin Foundation to investigate inflammatory bowel disease.

Several Stanford Medicine investigators have received new or continuing grants from the Oakland-based Kenneth Rainin Foundation to understand and treat inflammatory bowel disease. The funding is part of the organization’s Synergy Awards program, which supports teams of researchers working on collaborative projects.

Recipients include:

  • Karla Kirkegaard, PhD, the Violetta L. Horton Research Professor and professor of genetics and of microbiology and immunology, who, together with a researcher from UCLA, received $200,000 to investigate the relationship between inflammation in inflammatory bowel disease and a type of long, noncoding RNA.
  • Stephan Rogalla, MD, instructor of radiology and of medicine; Sarah Streett, MD, clinical associate professor of medicine; Garry Nolan, PhD, the Rachford and Carlota Harris Professor and professor of microbiology and immunology; and Aaron Meyer, a graduate student in bioengineering; received $300,000 to develop a personalized therapy for IBD by analyzing biomarkers using mass cytometry and multiplexed ion beam imaging.
  • Aida Habtezion, MD, associate professor of medicine; Sidhartha Sinha, MD, assistant professor of medicine; and Justin Sonnenburg, PhD, associate professor of microbiology and immunology; received a continuing award of $300,000 to examine how secondary bile acids affect intestinal inflammation. 

Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at

2021 ISSUE 2

Unlocking the secrets of the brain

COVID-19 Updates

Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.